The Academic Health Center (AHC) of the University of Minnesota proposes to expand its Training Program in Clinical Research with this application of the new Clinical Research Curriculum Award (K30). Involving all of the schools of the AHC (Dentistry, Medicine, Nursing, Pharmacy and Public Health), this multi-disciplinary program results in a Master of Science (MS) Graduate School degree in Clinical Research. The program draws heavily on the large and well-supported clinical research base within the AHC and a history of training successful clinical research scholars. It is grounded on formal classroom work in biostatistics, epidemiology, ethics, statistical computing, clinical research and other related fields. It requires a thesis based on an original clinical research project, an oral defense and a publishable manuscript. The program has a current class of 21. With- the support of this training grant, we anticipate a total of 20 trainees per year in a 2-4 year academic program. The program will enroll trainees drawn from all the clinical disciplines of the AHC which currently includes approximately 1,000 residents and fellows. In addition, recruiting of trainees will include national searches. Trainees have an advanced health professional degree (MD, DDS, DMD, DO, DC, OD, PharmD, or PhD in a clinical field) and have completed all or a substantial part of their clinical training. Rigorous admission standards and careful quality monitoring of each step in the training experience should result in graduates who are well trained clinical scholars and who will become contributors to the health of patients and the public. The curriculum is based on 7 learning objectives with measurable outcomes (didactic course work, grant writing and oral defense of a """"""""hands on"""""""" project) with attention to 3 general areas (knowledge, skills and ethics).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Research Curriculum Award (CRCA) (K30)
Project #
5K30HL004104-02
Application #
6388571
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S3))
Program Officer
Friedman, Lawrence
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$200,000
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Glasser, Stephen P; Khodneva, Yulia (2015) Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events? Hypertension 65:991-2
Bhatt, Hemal; Safford, Monika; Glasser, Stephen (2015) Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Curr Hypertens Rep 17:541
Glasser, Stephen P; Hovater, Martha; Brown, Todd M et al. (2014) Aspirin as Primary Prevention of Acute Coronary Heart Disease Events. Br J Med Med Res 4:5357-5367
Acelajado, Maria Czarina; Pisoni, Roberto; Dudenbostel, Tanja et al. (2012) Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J Am Soc Hypertens 6:66-72
Glasser, Stephen P; Dudenbostel, Tanja (2011) The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging Biomarkers. Curr Cardiovasc Risk Rep 5:187-195
Glasser, Stephen P; Wojczynski, Mary K; Oberman, A I et al. (2010) Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study. SRX Pharmacol 2010:485146
Glasser, Stephen P; Basile, Jan N; Lackland, Daniel T (2009) Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? Hypertension 54:954-5
Rapp, J H (1990) Basic data related to lipid abnormalities in peripheral vascular disease. Ann Vasc Surg 4:604-8